首页 > 最新文献

Infectious disorders drug targets最新文献

英文 中文
Advancing HIV Management in Prisons: A Decade of Protocol Development, Implementation, and Expansion in Iran (2014-2024). 推进监狱中的艾滋病管理:伊朗协议制定、实施和扩展十年(2014-2024 年)。
Pub Date : 2024-09-19 DOI: 10.2174/0118715265303162240822042117
SeyedAhmad SeyedAlinaghi, Ava Pashaei, Esmaeil Mehraeen, Omid Dadras
{"title":"Advancing HIV Management in Prisons: A Decade of Protocol Development, Implementation, and Expansion in Iran (2014-2024).","authors":"SeyedAhmad SeyedAlinaghi, Ava Pashaei, Esmaeil Mehraeen, Omid Dadras","doi":"10.2174/0118715265303162240822042117","DOIUrl":"https://doi.org/10.2174/0118715265303162240822042117","url":null,"abstract":"","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Current Perspective on the Effects of Flavonoids in the Treatment of Acne. 黄酮类化合物治疗痤疮效果的当前视角。
Pub Date : 2024-09-18 DOI: 10.2174/0118715265299763240818161040
Shikha Yadav, Pratichi Singh, Javed Khan, Swetanshu Singh

Pimples, blackheads, whiteheads, etc., are common types of acne that pop up on the skin each time, whenever dead cells and oils obstruct the outgrowth of hair from the hair follicle. It is very common to observe this condition in teenagers, but regardless of age, if the causing condition is met, acne can occur at any point in life. The characteristic feature of all types of acne is it starts with inflammation of the skin. These inflammatory marks (like black spots, pores, small scars, etc.) leave behind even when acne disappears. Plants like vegetables and flowers are naturally rich in different types of polyphenolic compounds called flavonoids. These flavonoids have various key functions, from guiding cell movement to maintaining oxidative pressure in the body. In this study, we discuss six types of flavonoids that have the potential to be used as med-icine for the treatment of different kinds of skin breakouts. Moreover, the result of molecular docking of different proteins that have an association with acne is also discussed.

粉刺、黑头粉刺、白头粉刺等都是常见的痤疮类型,每当死细胞和油脂阻碍毛囊中毛发的生长时,皮肤上就会冒出这些粉刺。这种情况在青少年身上很常见,但无论年龄大小,只要符合致病条件,痤疮在人生的任何阶段都可能出现。所有类型的痤疮都有一个特点,那就是一开始皮肤就会发炎。这些炎症痕迹(如黑点、毛孔、小疤痕等)即使在痤疮消失后也会留下。蔬菜和花卉等植物天然富含不同类型的多酚化合物,即类黄酮。这些类黄酮具有各种关键功能,从引导细胞运动到维持体内氧化压力。在这项研究中,我们讨论了六种有可能被用作治疗各种皮肤问题的药物的类黄酮。此外,还讨论了与痤疮有关的不同蛋白质的分子对接结果。
{"title":"A Current Perspective on the Effects of Flavonoids in the Treatment of Acne.","authors":"Shikha Yadav, Pratichi Singh, Javed Khan, Swetanshu Singh","doi":"10.2174/0118715265299763240818161040","DOIUrl":"https://doi.org/10.2174/0118715265299763240818161040","url":null,"abstract":"<p><p>Pimples, blackheads, whiteheads, etc., are common types of acne that pop up on the skin each time, whenever dead cells and oils obstruct the outgrowth of hair from the hair follicle. It is very common to observe this condition in teenagers, but regardless of age, if the causing condition is met, acne can occur at any point in life. The characteristic feature of all types of acne is it starts with inflammation of the skin. These inflammatory marks (like black spots, pores, small scars, etc.) leave behind even when acne disappears. Plants like vegetables and flowers are naturally rich in different types of polyphenolic compounds called flavonoids. These flavonoids have various key functions, from guiding cell movement to maintaining oxidative pressure in the body. In this study, we discuss six types of flavonoids that have the potential to be used as med-icine for the treatment of different kinds of skin breakouts. Moreover, the result of molecular docking of different proteins that have an association with acne is also discussed.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142305513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review over Mitochondrial Diseases Due to mtDNA Mutations: Recent Advances and Remedial Aspects. 关于 mtDNA 突变导致的线粒体疾病的综述:最新进展和补救措施。
Pub Date : 2024-09-04 DOI: 10.2174/0118715265304029240801092834
Alok Bharadwaj

Mitochondria, also called 'powerhouse of the cell', is meant for energy generation in eukaryotic cells. This action is performed by mitochondria through the oxidative phosphor-ylation (OXPHOS) of the respiratory chain (RC). Based on the functioning of the cell, the number of mitochondria varies up to thousands in number. Mutations in the mitochondrial DNA (mtDNA) and/or nuclear DNA (nDNA) genes may lead to the generation of primary mitochondrial disease (PMD) that affects the structure and function of mitochondria. The di-agnosis of such mitochondrial diseases occurs in early childhood and it can lead to serious, fetal and multi-organ diseases. Understanding epigenetic events and changes in the pathway can help improve the effectiveness of treatment. However, there are several reasons lack of the disease symptoms (age, sign, symptoms, morbidity and lethality), restricted availability of pre-clinical models along with extensive phenotypes that hamper the development of efficient drugs. Despite the introduction of new treatments and the encouraging results of treatments and therapies, there is no effective cure for PMD. This article contains information about the changes associated with cytopathic diseases that make possible the analysis of various diseases by genetic techniques. Increasing our under-standing of how mitochondrial DNA mutations affect mitochondrial metabolism and subse-quently result in neurodegenerative disease will prove vital to the development of targeted therapies and treatments.

线粒体也被称为 "细胞的动力室",在真核细胞中负责产生能量。线粒体通过呼吸链(RC)的氧化磷酸化(OXPHOS)来完成这一动作。根据细胞的功能,线粒体的数量最多可达数千个。线粒体 DNA(mtDNA)和/或核 DNA(nDNA)基因突变可能导致原发性线粒体疾病(PMD)的产生,从而影响线粒体的结构和功能。这种线粒体疾病的双重诊断发生在儿童早期,可导致严重的胎儿疾病和多器官疾病。了解表观遗传事件和通路的变化有助于提高治疗效果。然而,由于缺乏疾病症状(年龄、体征、症状、发病率和致死率)、临床前模型有限以及表型广泛等原因,阻碍了高效药物的开发。尽管引入了新的治疗方法,治疗和疗法也取得了令人鼓舞的成果,但目前还没有有效治愈 PMD 的方法。本文介绍了与细胞病理学疾病相关的变化,这些变化使得通过基因技术分析各种疾病成为可能。加深我们对线粒体DNA突变如何影响线粒体代谢并继而导致神经退行性疾病的了解,对于开发靶向疗法和治疗方法至关重要。
{"title":"A Review over Mitochondrial Diseases Due to mtDNA Mutations: Recent Advances and Remedial Aspects.","authors":"Alok Bharadwaj","doi":"10.2174/0118715265304029240801092834","DOIUrl":"https://doi.org/10.2174/0118715265304029240801092834","url":null,"abstract":"<p><p>Mitochondria, also called 'powerhouse of the cell', is meant for energy generation in eukaryotic cells. This action is performed by mitochondria through the oxidative phosphor-ylation (OXPHOS) of the respiratory chain (RC). Based on the functioning of the cell, the number of mitochondria varies up to thousands in number. Mutations in the mitochondrial DNA (mtDNA) and/or nuclear DNA (nDNA) genes may lead to the generation of primary mitochondrial disease (PMD) that affects the structure and function of mitochondria. The di-agnosis of such mitochondrial diseases occurs in early childhood and it can lead to serious, fetal and multi-organ diseases. Understanding epigenetic events and changes in the pathway can help improve the effectiveness of treatment. However, there are several reasons lack of the disease symptoms (age, sign, symptoms, morbidity and lethality), restricted availability of pre-clinical models along with extensive phenotypes that hamper the development of efficient drugs. Despite the introduction of new treatments and the encouraging results of treatments and therapies, there is no effective cure for PMD. This article contains information about the changes associated with cytopathic diseases that make possible the analysis of various diseases by genetic techniques. Increasing our under-standing of how mitochondrial DNA mutations affect mitochondrial metabolism and subse-quently result in neurodegenerative disease will prove vital to the development of targeted therapies and treatments.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142135049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biological Mechanisms of Polyphenols against Clostridium Difficile: A Systematic Review. 多酚抗艰难梭菌的生物机制:系统综述。
Pub Date : 2024-09-04 DOI: 10.2174/0118715265313944240726115600
Mohammad Darvishi, Seyed Mahmoud Reza Hashemi Rafsanjani, Majid Nouri, Saber Abbaszadeh, Saeid Heidari-Soureshjani, Karamali Kasiri, Ghorbanali Rahimian

Background: Clostridium difficile is an opportunistic infection that can lead to antibi-otic-associated diarrhea and toxic megacolon.

Objective: This systematic review study aimed to investigate polyphenols' antibacterial and anti-toxin properties and their effects on reducing complications related to C. difficile Infections (CDI).

Methods: This systematic review was conducted following the PRISMA guideline 2020. Multiple databases, including Web of Science, PubMed, Cochrane Library, EMBASE, and Scopus, were searched thoroughly for existing literature. After considering the inclusion and exclusion criteria for the review, 18 articles were included. Data were collected and registered into an Excel file for further investigations and conclusions.

Results: Polyphenols by reducing Reactive Oxygen Species (ROS) levels, increasing inflammatory factor Interleukin 10 (IL-10), reducing Nuclear Factor kappa B (NF-κB) and Tumour Necrosis Fac-tor-α (TNF-α), IL-6, IL-1α, IL-1β, Granulocyte Colony-stimulating Factor (G-CSF), and Monocyte Chemoattractant Protein-1 (MCP-1) and Macrophage Inflammatory Protein-1 alpha (MIP-1α) lev-els, and regulating the expression of Bcl-2 and Bax, make the growth and replication conditions of C. difficile more difficult and prevent it from producing toxins. Furthermore, polyphenols can ex-hibit prebiotic properties, promoting the growth of beneficial Bifidobacterium and Lactobacillus species and consequently regulating gut microbiota, exerting antimicrobial activities against C. dif-ficile. They also induce their beneficial effects by inhibiting the production of C. difficile TcdA and TcdB.

Conclusion: Polyphenols have been reported to inhibit C. difficile growth and toxin production by several mechanisms in preclinical studies. However, more clinical studies are needed to investigate their safety in humans.

背景:艰难梭菌是一种机会性感染,可导致抗生素相关性腹泻和中毒性巨结肠:艰难梭菌是一种机会性感染,可导致抗生素相关性腹泻和中毒性巨结肠症:本系统综述研究旨在调查多酚的抗菌和抗毒素特性及其对减少艰难梭菌感染(CDI)相关并发症的作用:本系统性综述是按照《PRISMA 2020》指南进行的。对多个数据库(包括 Web of Science、PubMed、Cochrane Library、EMBASE 和 Scopus)中的现有文献进行了全面检索。在考虑了综述的纳入和排除标准后,共纳入了 18 篇文章。数据被收集并登记到 Excel 文件中,以便进一步调查和得出结论:多酚可降低活性氧(ROS)水平,增加炎症因子白细胞介素 10(IL-10),减少核因子卡巴 B(NF-κB)和肿瘤坏死因子-α(TNF-α)、IL-6、IL-1α、IL-1β、α(TNF-κB)、IL-6、IL-1α、IL-1β、粒细胞集落刺激因子(G-CSF)、单核细胞趋化蛋白-1(MCP-1)和巨噬细胞炎症蛋白-1α(MIP-1α)的水平,并调节 Bcl-2 和 Bax 的表达,从而使艰难梭菌的生长和复制条件变得更加困难,并阻止其生长。多酚能使艰难梭菌更难生长和复制,并阻止其产生毒素。此外,多酚还能抑制益生元特性,促进有益的双歧杆菌和乳酸杆菌的生长,从而调节肠道微生物群,对艰难梭菌发挥抗菌作用。它们还能通过抑制艰难梭菌 TcdA 和 TcdB 的产生而产生有益效果:结论:在临床前研究中,多酚通过多种机制抑制艰难梭菌的生长和毒素的产生。然而,还需要更多的临床研究来调查它们对人体的安全性。
{"title":"Biological Mechanisms of Polyphenols against Clostridium Difficile: A Systematic Review.","authors":"Mohammad Darvishi, Seyed Mahmoud Reza Hashemi Rafsanjani, Majid Nouri, Saber Abbaszadeh, Saeid Heidari-Soureshjani, Karamali Kasiri, Ghorbanali Rahimian","doi":"10.2174/0118715265313944240726115600","DOIUrl":"https://doi.org/10.2174/0118715265313944240726115600","url":null,"abstract":"<p><strong>Background: </strong>Clostridium difficile is an opportunistic infection that can lead to antibi-otic-associated diarrhea and toxic megacolon.</p><p><strong>Objective: </strong>This systematic review study aimed to investigate polyphenols' antibacterial and anti-toxin properties and their effects on reducing complications related to C. difficile Infections (CDI).</p><p><strong>Methods: </strong>This systematic review was conducted following the PRISMA guideline 2020. Multiple databases, including Web of Science, PubMed, Cochrane Library, EMBASE, and Scopus, were searched thoroughly for existing literature. After considering the inclusion and exclusion criteria for the review, 18 articles were included. Data were collected and registered into an Excel file for further investigations and conclusions.</p><p><strong>Results: </strong>Polyphenols by reducing Reactive Oxygen Species (ROS) levels, increasing inflammatory factor Interleukin 10 (IL-10), reducing Nuclear Factor kappa B (NF-κB) and Tumour Necrosis Fac-tor-α (TNF-α), IL-6, IL-1α, IL-1β, Granulocyte Colony-stimulating Factor (G-CSF), and Monocyte Chemoattractant Protein-1 (MCP-1) and Macrophage Inflammatory Protein-1 alpha (MIP-1α) lev-els, and regulating the expression of Bcl-2 and Bax, make the growth and replication conditions of C. difficile more difficult and prevent it from producing toxins. Furthermore, polyphenols can ex-hibit prebiotic properties, promoting the growth of beneficial Bifidobacterium and Lactobacillus species and consequently regulating gut microbiota, exerting antimicrobial activities against C. dif-ficile. They also induce their beneficial effects by inhibiting the production of C. difficile TcdA and TcdB.</p><p><strong>Conclusion: </strong>Polyphenols have been reported to inhibit C. difficile growth and toxin production by several mechanisms in preclinical studies. However, more clinical studies are needed to investigate their safety in humans.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142135050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Host Risk Factors for Tuberculosis. 结核病的宿主风险因素。
Pub Date : 2024-09-03 DOI: 10.2174/0118715265304343240722190414
Vahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Mohammad Asgharzadeh, Jalil Rashedi, Hossein Samadi Kafil, Hossein Jalaei Nobari, Ahmad Ali Khalili, Mortaza Raeisi, Mahdi Asghari Ozma, Behroz Mahdavi Poor

Tuberculosis (TB) spreads through droplets that contain Mycobacterium tuberculosis (Mtb) and can infect susceptible people. Due to different risk factors, people have different susceptibility ranges towards TB. The risk factors are classified into three main groups, includ-ing bacterial, environmental, and host factors. Literature review reveals that the most important host risk factors are aging, male gender, genetics, epigenetics, having an impaired immune system, diabetes, malignancy, malnutrition, anemia, and pregnancy. The risk factors contribute to the increase in TB cases through inflammation, increased contact with TB patients, disrup-tion of immune genes, changes in gene expression, increased activity of Mtb, damage to cellu-lar immunity, reactivation of Latent TB Infection (LTBI), increased susceptibility to TB, com-promised immunity, and changes in the proportion of T cell subgroups, respectively. Therefore, identification of the infection source and high-risk people and timely treatment of the patients can reduce TB mortality and help control the disease.

结核病(TB)通过含有结核分枝杆菌(Mtb)的飞沫传播,可感染易感人群。由于风险因素不同,人们对结核病的易感范围也不同。风险因素主要分为三类,包括细菌因素、环境因素和宿主因素。文献综述显示,最重要的宿主风险因素是衰老、男性性别、遗传学、表观遗传学、免疫系统受损、糖尿病、恶性肿瘤、营养不良、贫血和妊娠。这些风险因素分别通过炎症、与肺结核患者接触增多、免疫基因紊乱、基因表达改变、Mtb活性增强、细胞免疫受损、潜伏肺结核感染(LTBI)再活化、肺结核易感性增加、免疫力受损和T细胞亚群比例改变等途径导致肺结核病例增加。因此,识别传染源和高危人群,及时治疗患者,可以降低结核病死亡率,有助于控制结核病。
{"title":"Host Risk Factors for Tuberculosis.","authors":"Vahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Mohammad Asgharzadeh, Jalil Rashedi, Hossein Samadi Kafil, Hossein Jalaei Nobari, Ahmad Ali Khalili, Mortaza Raeisi, Mahdi Asghari Ozma, Behroz Mahdavi Poor","doi":"10.2174/0118715265304343240722190414","DOIUrl":"https://doi.org/10.2174/0118715265304343240722190414","url":null,"abstract":"<p><p>Tuberculosis (TB) spreads through droplets that contain Mycobacterium tuberculosis (Mtb) and can infect susceptible people. Due to different risk factors, people have different susceptibility ranges towards TB. The risk factors are classified into three main groups, includ-ing bacterial, environmental, and host factors. Literature review reveals that the most important host risk factors are aging, male gender, genetics, epigenetics, having an impaired immune system, diabetes, malignancy, malnutrition, anemia, and pregnancy. The risk factors contribute to the increase in TB cases through inflammation, increased contact with TB patients, disrup-tion of immune genes, changes in gene expression, increased activity of Mtb, damage to cellu-lar immunity, reactivation of Latent TB Infection (LTBI), increased susceptibility to TB, com-promised immunity, and changes in the proportion of T cell subgroups, respectively. Therefore, identification of the infection source and high-risk people and timely treatment of the patients can reduce TB mortality and help control the disease.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design of RNA Polymerase Inhibitors as Therapeutics for Tuberculous Meningitis. 设计 RNA 聚合酶抑制剂作为治疗结核性脑膜炎的药物。
Pub Date : 2024-09-02 DOI: 10.2174/0118715265341228240827062721
Varalakshmi Vummidi, Sekhar Talluri

Background: Tuberculosis is an infectious disease caused by Mycobacterium tuber-culosis. The current treatment protocols for pulmonary tuberculosis are quite effective, even though the treatment requires 3-6 months. The current treatment protocols for extrapulmonary tuberculosis are based on the same drugs that are used for pulmonary tuberculosis. However, the success rates are much lower for certain types of extrapulmonary tuberculosis, such as tubercu-lous meningitis. Tuberculous meningitis is one of the very few diseases attributable to bacteria that have a very high short-term mortality rate among diagnosed patients, even after treatment with antibiotics that are effective for pulmonary tuberculosis. For example, rifampicin is highly effective for the treatment of pulmonary tuberculosis, but its effectiveness for the treatment of tuberculous meningitis is much lower. The reason for the lower effectiveness of rifampicin against tuberculous meningitis is that it has low Blood-Brain Barrier (BBB) permeability, which results in lower concentrations of the drug at the required sites in the central nervous system.

Methods: In this work, ligands having improved BBB permeability and pharmacokinetic and pharmacodynamic properties, either similar to or better than that of rifampicin, have been designed. The BBB permeability of the designed molecules was assessed by using pkCSM, a machine-learning model. Pharmacokinetic properties, drug-likeness, and synthesizability were assessed by using SWISS-MODEL. The binding affinity of the designed drugs was assessed by using AutoDock Vina. A customized scoring function, StWN score, was used for a quantitative weighted assessment of all the properties of interest to rank the designed molecules.

Results: In this study, drug-like ligands have been designed that have been predicted to have high BBB permeability as well as high affinity for RNA polymerase β of Mycobacterium tuberculosis.

Conclusion: The best ligands generated by the tools employed were selected as potential drugs to address the current need for better options for the treatment of tuberculous meningitis.

背景:肺结核是一种由结核分枝杆菌引起的传染性疾病。目前治疗肺结核的方案相当有效,尽管治疗时间需要 3-6 个月。目前治疗肺外结核病的方案与治疗肺结核的药物相同。然而,对于某些类型的肺外结核病,如结核性脑膜炎,成功率要低得多。结核性脑膜炎是极少数由细菌引起的疾病之一,即使使用对肺结核有效的抗生素治疗,确诊患者的短期死亡率也非常高。例如,利福平对治疗肺结核非常有效,但对治疗结核性脑膜炎的疗效却低得多。利福平对结核性脑膜炎疗效较低的原因是它的血脑屏障(BBB)通透性低,导致药物在中枢神经系统所需部位的浓度较低:方法:在这项工作中,我们设计了一些配体,这些配体的血脑屏障通透性增加,药代动力学和药效学特性与利福平相似或优于利福平。所设计分子的 BBB 通透性是通过马-奇学习模型 pkCSM 评估的。使用 SWISS-MODEL 评估了药物代谢特性、药物相似性和可合成性。使用 AutoDock Vina 评估了所设计药物的结合亲和力。使用定制的评分函数 StWN score 对所有相关特性进行量化加权评估,从而对设计的分子进行排序:结果:本研究设计出的药物配体被预测为具有高 BBB 渗透性以及对结核分枝杆菌的 RNA 聚合酶  具有高亲和力:结论:通过所使用的工具产生的最佳配体被选为潜在药物,以满足当前治疗结核性脑膜炎对更好选择的需求。
{"title":"Design of RNA Polymerase Inhibitors as Therapeutics for Tuberculous Meningitis.","authors":"Varalakshmi Vummidi, Sekhar Talluri","doi":"10.2174/0118715265341228240827062721","DOIUrl":"10.2174/0118715265341228240827062721","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis is an infectious disease caused by Mycobacterium tuber-culosis. The current treatment protocols for pulmonary tuberculosis are quite effective, even though the treatment requires 3-6 months. The current treatment protocols for extrapulmonary tuberculosis are based on the same drugs that are used for pulmonary tuberculosis. However, the success rates are much lower for certain types of extrapulmonary tuberculosis, such as tubercu-lous meningitis. Tuberculous meningitis is one of the very few diseases attributable to bacteria that have a very high short-term mortality rate among diagnosed patients, even after treatment with antibiotics that are effective for pulmonary tuberculosis. For example, rifampicin is highly effective for the treatment of pulmonary tuberculosis, but its effectiveness for the treatment of tuberculous meningitis is much lower. The reason for the lower effectiveness of rifampicin against tuberculous meningitis is that it has low Blood-Brain Barrier (BBB) permeability, which results in lower concentrations of the drug at the required sites in the central nervous system.</p><p><strong>Methods: </strong>In this work, ligands having improved BBB permeability and pharmacokinetic and pharmacodynamic properties, either similar to or better than that of rifampicin, have been designed. The BBB permeability of the designed molecules was assessed by using pkCSM, a machine-learning model. Pharmacokinetic properties, drug-likeness, and synthesizability were assessed by using SWISS-MODEL. The binding affinity of the designed drugs was assessed by using AutoDock Vina. A customized scoring function, StWN score, was used for a quantitative weighted assessment of all the properties of interest to rank the designed molecules.</p><p><strong>Results: </strong>In this study, drug-like ligands have been designed that have been predicted to have high BBB permeability as well as high affinity for RNA polymerase β of Mycobacterium tuberculosis.</p><p><strong>Conclusion: </strong>The best ligands generated by the tools employed were selected as potential drugs to address the current need for better options for the treatment of tuberculous meningitis.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142121498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of Antibiotic Actinomycin D Isolated from Streptomyces parvulus Collected from Marine Sponge of Barrang Lompo Island, Makassar, Indonesia. 从印度尼西亚望加锡 Barrang Lompo 岛海洋海绵中采集的链霉菌中分离出的抗生素放线菌素 D 的特征。
Pub Date : 2024-08-26 DOI: 10.2174/0118715265306848240719061135
Herlina Rante, Gemini Alam, Yosi Bayu Murti, Alimuddin Ali

Background: Microorganisms associated with sea sponges have proven to be good natural product resources that are biologically active and pharmaceutically important.

Objective: This research aimed to identify actinomycetes related to a sponge from Bar-ranglompo Island Makassar and the antibacterial compounds.

Methods: Identification of actinomycetes was based on molecular characterization of sequence gen16S rRNA. The antibacterial compound was separated using vacuum liquid chromatog-raphy and preparative Thin Layer Chromatography (TLC). The structure determination was done based on spectroscopy 1H-NMR, 13C-NMR, 2D NMR, and mass spectra.

Results: Molecular characterization showed that actinomycetes strain BLP 20 had the closest relationship with Streptomyces parvulus and Uncultured Streptomyces sp. with a similarity value of 83%. The results obtained from the characterization of antibacterial compounds based on spectroscopic data indicate that these compounds lead to Actinomycin D.

Conclusion: Characterization and identification of Strain 20 / BLP by molecular phylogenetic analysis of 16S rRNA sequences revealed the closest relationship with Uncultured Streptomy-ces sp and S. parvulus with a similarity value of 83 %, which indicated a new species. The structure of the active compound isolated from actinomycetes strain 20 / BLP leads to Actino-mycin D.

背景:与海海绵相关的微生物已被证明是具有生物活性和重要药用价值的良好天然产品资源:本研究旨在鉴定与望加锡 Bar-ranglompo 岛海绵有关的放线菌及其抗菌化合物:放线菌的鉴定基于基因 16S rRNA 序列的分子特征。使用真空液相色谱法和制备型薄层色谱法(TLC)分离抗菌化合物。根据 1H-NMR、13C-NMR、2D NMR 和质谱进行了结构测定:分子鉴定结果表明,放线菌菌株 BLP 20 与副链霉菌(Streptomyces parvulus)和未培养链霉菌(Uncultured Streptomyces sp.根据光谱数据对抗菌化合物进行表征的结果表明,这些化合物可产生放线菌素 D:通过 16S rRNA 序列的分子系统进化分析,对菌株 20 / BLP 进行了特征描述和鉴定,发现其与未培养的 Streptomy-ces sp 和 S. parvulus 的关系最为密切,相似度为 83%,这表明这是一个新物种。从放线菌菌株 20 / BLP 中分离出的活性化合物的结构为放线菌素 D。
{"title":"Characterization of Antibiotic Actinomycin D Isolated from Streptomyces parvulus Collected from Marine Sponge of Barrang Lompo Island, Makassar, Indonesia.","authors":"Herlina Rante, Gemini Alam, Yosi Bayu Murti, Alimuddin Ali","doi":"10.2174/0118715265306848240719061135","DOIUrl":"https://doi.org/10.2174/0118715265306848240719061135","url":null,"abstract":"<p><strong>Background: </strong>Microorganisms associated with sea sponges have proven to be good natural product resources that are biologically active and pharmaceutically important.</p><p><strong>Objective: </strong>This research aimed to identify actinomycetes related to a sponge from Bar-ranglompo Island Makassar and the antibacterial compounds.</p><p><strong>Methods: </strong>Identification of actinomycetes was based on molecular characterization of sequence gen16S rRNA. The antibacterial compound was separated using vacuum liquid chromatog-raphy and preparative Thin Layer Chromatography (TLC). The structure determination was done based on spectroscopy 1H-NMR, 13C-NMR, 2D NMR, and mass spectra.</p><p><strong>Results: </strong>Molecular characterization showed that actinomycetes strain BLP 20 had the closest relationship with Streptomyces parvulus and Uncultured Streptomyces sp. with a similarity value of 83%. The results obtained from the characterization of antibacterial compounds based on spectroscopic data indicate that these compounds lead to Actinomycin D.</p><p><strong>Conclusion: </strong>Characterization and identification of Strain 20 / BLP by molecular phylogenetic analysis of 16S rRNA sequences revealed the closest relationship with Uncultured Streptomy-ces sp and S. parvulus with a similarity value of 83 %, which indicated a new species. The structure of the active compound isolated from actinomycetes strain 20 / BLP leads to Actino-mycin D.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142083030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug Discovery and Exploration of Heterocycles for the Development of Anti-HIV Agents. 用于开发抗艾滋病毒药物的杂环化合物的药物发现和探索。
Pub Date : 2024-08-23 DOI: 10.2174/0118715265290911240611072422
Mayura A Kale, Mamata V Jain

It is a known fact that HIV infection remains a serious public health problem throughout the world, and the need to constantly develop new antiretroviral drugs to combat HIV emerges from the fact that repetitive mutations occurring in viral enzymes make this virus resistant to antiretroviral drugs. This resistance causes failure of treatment, and hence, for many years, extensive research has been to discover newer possibilities for fighting this disease at a molecular level, along with many long-standing and expensive clinical trials. Many scientific research programs have either been discarded or unsuccessful. However, the research has not stopped, and in the process, many heterocyclic scaffolds have been used to build up novel drug molecules to combat this disease. A literature survey reveals that many heterocycles have been explored and were found to be very useful in treating different types of viral infections. This concise and rigorous literature explains the journey and highlights the various strategies to develop new anti-HIV drug candidates.

众所周知,艾滋病病毒感染仍然是全世界严重的公共卫生问题,由于病毒酶发生重复突变,使病毒对抗逆转录病毒药物产生耐药性,因此需要不断开发新的抗逆转录病毒药物来抗击艾滋病病毒。这种抗药性导致治疗失败,因此,多年来,人们一直在进行广泛的研究,以便从分子水平上发现抗击这种疾病的新的可能性,同时还进行了许多旷日持久、耗资巨大的临床试验。许多科研项目要么被放弃,要么不成功。然而,研究并没有停止,在这一过程中,许多杂环支架被用来构建新的药物分子来对抗这种疾病。文献调查显示,许多杂环化合物已被探索出来,并被发现在治疗不同类型的病毒感染方面非常有用。这本简明而严谨的文献阐述了这一历程,并重点介绍了开发新型抗艾滋病毒候选药物的各种策略。
{"title":"Drug Discovery and Exploration of Heterocycles for the Development of Anti-HIV Agents.","authors":"Mayura A Kale, Mamata V Jain","doi":"10.2174/0118715265290911240611072422","DOIUrl":"https://doi.org/10.2174/0118715265290911240611072422","url":null,"abstract":"<p><p>It is a known fact that HIV infection remains a serious public health problem throughout the world, and the need to constantly develop new antiretroviral drugs to combat HIV emerges from the fact that repetitive mutations occurring in viral enzymes make this virus resistant to antiretroviral drugs. This resistance causes failure of treatment, and hence, for many years, extensive research has been to discover newer possibilities for fighting this disease at a molecular level, along with many long-standing and expensive clinical trials. Many scientific research programs have either been discarded or unsuccessful. However, the research has not stopped, and in the process, many heterocyclic scaffolds have been used to build up novel drug molecules to combat this disease. A literature survey reveals that many heterocycles have been explored and were found to be very useful in treating different types of viral infections. This concise and rigorous literature explains the journey and highlights the various strategies to develop new anti-HIV drug candidates.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Review of the Difficulties Faced by Low and Middle-income Countries in Hygiene and Healthcare Practices. 中低收入国家在卫生和保健实践中面临的困难综述》。
Pub Date : 2024-08-19 DOI: 10.2174/0118715265307717240713182628
Jashan Girdhar, Kapil Shandilya, Munnawar Husaain, Parneet Kaur, Shushank Mahajan, Tarun Singh, Isha Chawla, Meenakshi Dhanawat

Hygiene has been identified as an important step in anticipating health-related pol-lution, with conflicting reports about consistent sanitation standards in the nation. This narrative review of published studies has led to the discussion of hand hygiene and health practices, as well as the identification of necessary methods that are available in low and middle-income countries. An effective survey of accessible information is conducted in this way based on re-view questions. A number of 372 articles were found on the web, and 32 articles were used in the final analysis. Overall, the standard of hand hygiene is set at 20.49%. Difficulties identified for the people in low or middle-income countries are poor awareness and sound information about hand hygiene, lack of resources including water, soap, hand scrubbing gel, etc., as mis-interpretations related to hand hygiene practices. People are paying more attention to healthcare-related illnesses as it becomes increasingly clear that most of them may be pre-vented. The free evidence-based practice states that to lower the danger of contamination, hand hygiene should be properly adhered to. The difficulties recognized in this review are reliable, with the discoveries of studies that have been led somewhere else. By conducting a basic ex-amination of the "Clean Care is Safer Care" as an excellent arrangement of WHO's global initiative activity on patient well-being programs, developing nations will have more time to consider the essential approaches for the use of fundamental disease prevention exercises in our health care settings.

卫生被认为是预防与健康有关的污染的重要步骤,但关于国家卫生标准是否一致的报道却相互矛盾。通过对已发表研究的叙述性回顾,我们对手卫生和健康习惯进行了讨论,并确定了中低收入国家可用的必要方法。通过这种方式,可以根据重审问题对可获取的信息进行有效调查。在网络上共找到 372 篇文章,其中 32 篇文章被用于最终分析。总体而言,手部卫生标准为 20.49%。低收入或中等收入国家的人们面临的困难是对手部卫生的认识不足和信息不全,缺乏资源,包括水、肥皂、洗手液等,以及对手部卫生做法的误解。人们越来越关注与医疗保健相关的疾病,因为人们越来越清楚地认识到,大多数疾病都可能是预先感染的。免费的循证实践表明,要降低污染的危险,就应适当坚持手部卫生。本综述认识到的困难是可靠的,但也发现了一些其他方面的研究。通过对 "清洁护理是更安全的护理 "这一世卫组织全球患者福利计划活动的出色安排进行基本审查,发展中国家将有更多时间考虑在我们的医疗保健环境中使用基本疾病预防措施的基本方法。
{"title":"A Review of the Difficulties Faced by Low and Middle-income Countries in Hygiene and Healthcare Practices.","authors":"Jashan Girdhar, Kapil Shandilya, Munnawar Husaain, Parneet Kaur, Shushank Mahajan, Tarun Singh, Isha Chawla, Meenakshi Dhanawat","doi":"10.2174/0118715265307717240713182628","DOIUrl":"https://doi.org/10.2174/0118715265307717240713182628","url":null,"abstract":"<p><p>Hygiene has been identified as an important step in anticipating health-related pol-lution, with conflicting reports about consistent sanitation standards in the nation. This narrative review of published studies has led to the discussion of hand hygiene and health practices, as well as the identification of necessary methods that are available in low and middle-income countries. An effective survey of accessible information is conducted in this way based on re-view questions. A number of 372 articles were found on the web, and 32 articles were used in the final analysis. Overall, the standard of hand hygiene is set at 20.49%. Difficulties identified for the people in low or middle-income countries are poor awareness and sound information about hand hygiene, lack of resources including water, soap, hand scrubbing gel, etc., as mis-interpretations related to hand hygiene practices. People are paying more attention to healthcare-related illnesses as it becomes increasingly clear that most of them may be pre-vented. The free evidence-based practice states that to lower the danger of contamination, hand hygiene should be properly adhered to. The difficulties recognized in this review are reliable, with the discoveries of studies that have been led somewhere else. By conducting a basic ex-amination of the \"Clean Care is Safer Care\" as an excellent arrangement of WHO's global initiative activity on patient well-being programs, developing nations will have more time to consider the essential approaches for the use of fundamental disease prevention exercises in our health care settings.</p>","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142006218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confronting and Addressing the Presence of Psittacosis in Europe. 面对和解决欧洲的鹦鹉热问题。
Pub Date : 2024-08-16 DOI: 10.2174/0118715265322768240807102042
Shivang Saxena, Shubhi Saxena, Nihar Ranjan Sahoo, Amandeep Singh
{"title":"Confronting and Addressing the Presence of Psittacosis in Europe.","authors":"Shivang Saxena, Shubhi Saxena, Nihar Ranjan Sahoo, Amandeep Singh","doi":"10.2174/0118715265322768240807102042","DOIUrl":"https://doi.org/10.2174/0118715265322768240807102042","url":null,"abstract":"","PeriodicalId":101326,"journal":{"name":"Infectious disorders drug targets","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142006219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infectious disorders drug targets
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1